Adipose depot gene expression and intelectin‐1 in the metabolic response to cancer and cachexia
Abstract Background Cancer cachexia is a poorly understood metabolic consequence of cancer. During cachexia, different adipose depots demonstrate differential wasting rates. Animal models suggest adipose tissue may be a key driver of muscle wasting through fat-muscle crosstalk, but human studies in...
Saved in:
Main Authors: | Janice Miller (Author), Gillian Dreczkowski (Author), Michael I. Ramage (Author), Stephen J. Wigmore (Author), Iain J. Gallagher (Author), Richard J.E. Skipworth (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A systematic review examining the relationship between cytokines and cachexia in incurable cancer
by: D. Robert Paval, et al.
Published: (2022) -
Human Intelectin-1 (hITL-1) as Modulator of Metabolic Syndrome (MetS): An In Silico Study
by: Vishnupriya N, et al.
Published: (2024) -
Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic Agents
by: Bodil Bjørndal, et al.
Published: (2011) -
Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting
by: Dheeraj Kumar Posa, et al.
Published: (2023) -
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024)